Persistent URL of this record https://hdl.handle.net/1887/86376
Documents
-
- Download
- s41416-018-0310-8
- Publisher's Version
-
open access
- Full text at publishers site
In Collections
This item can be found in the following collections:
Ten-year results of the PORTEC-2 trial for high-intermediate risk endometrial carcinoma: improving patient selection for adjuvant therapy
- All authors
- Wortman, B.G.; Creutzberg, C.L.; Putter, H.; Jurgenliemk-Schulz, I.M.; Jobsen, J.J.; Lutgens, L.C.H.W.; Steen-Banasik, E.M. van der; Mens, J.W.M.; Slot, A.; Kroese, M.C.S.; Triest, B. van; Nijman, H.W.; Stelloo, E.; Bosse, T.; Boer, S.M. de; Putten, W.L.J. van; Smit, V.T.H.B.M.; Nout, R.A.; PORTEC Study Grp
- Date
- 2018-10-30
- Journal
- British Journal of Cancer
- Volume
- 119
- Issue
- 9
- Pages
- 1067 - 1074